Exact Mass: 502.2025

Exact Mass Matches: 502.2025

Found 51 metabolites which its exact mass value is equals to given mass value 502.2025, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Cys His Ile Met

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C20H34N6O5S2 (502.2032)


   

Cys His Leu Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C20H34N6O5S2 (502.2032)


   

Cys His Met Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanoic acid

C20H34N6O5S2 (502.2032)


   

Cys His Met Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanoic acid

C20H34N6O5S2 (502.2032)


   

Cys Ile His Met

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C20H34N6O5S2 (502.2032)


   

Cys Ile Met His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H34N6O5S2 (502.2032)


   

Cys Leu His Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C20H34N6O5S2 (502.2032)


   

Cys Leu Met His

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H34N6O5S2 (502.2032)


   

Cys Met His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C20H34N6O5S2 (502.2032)


   

Cys Met His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C20H34N6O5S2 (502.2032)


   

Cys Met Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H34N6O5S2 (502.2032)


   

Cys Met Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H34N6O5S2 (502.2032)


   

His Cys Ile Met

(2S)-2-[(2S,3S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C20H34N6O5S2 (502.2032)


   

His Cys Leu Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C20H34N6O5S2 (502.2032)


   

His Cys Met Ile

(2S,3S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanoic acid

C20H34N6O5S2 (502.2032)


   

His Cys Met Leu

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanoic acid

C20H34N6O5S2 (502.2032)


   

His Ile Cys Met

(2S)-2-[(2R)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C20H34N6O5S2 (502.2032)


   

His Ile Met Cys

(2R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C20H34N6O5S2 (502.2032)


   

His Leu Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C20H34N6O5S2 (502.2032)


   

His Leu Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C20H34N6O5S2 (502.2032)


   

His Met Cys Ile

(2S,3S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-methylpentanoic acid

C20H34N6O5S2 (502.2032)


   

His Met Cys Leu

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-methylpentanoic acid

C20H34N6O5S2 (502.2032)


   

His Met Ile Cys

(2R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanamido]-3-sulfanylpropanoic acid

C20H34N6O5S2 (502.2032)


   

His Met Leu Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanamido]-3-sulfanylpropanoic acid

C20H34N6O5S2 (502.2032)


   

Ile Cys His Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C20H34N6O5S2 (502.2032)


   

Ile Cys Met His

(2S)-2-[(2S)-2-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H34N6O5S2 (502.2032)


   

Ile His Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C20H34N6O5S2 (502.2032)


   

Ile His Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C20H34N6O5S2 (502.2032)


   

Ile Met Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H34N6O5S2 (502.2032)


   

Ile Met His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C20H34N6O5S2 (502.2032)


   

Leu Cys His Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C20H34N6O5S2 (502.2032)


   

Leu Cys Met His

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H34N6O5S2 (502.2032)


   

Leu His Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C20H34N6O5S2 (502.2032)


   

Leu His Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C20H34N6O5S2 (502.2032)


   

Leu Met Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H34N6O5S2 (502.2032)


   

Leu Met His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C20H34N6O5S2 (502.2032)


   

Met Cys His Ile

(2S,3S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C20H34N6O5S2 (502.2032)


   

Met Cys His Leu

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C20H34N6O5S2 (502.2032)


   

Met Cys Ile His

(2S)-2-[(2S,3S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H34N6O5S2 (502.2032)


   

Met Cys Leu His

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H34N6O5S2 (502.2032)


   

Met His Cys Ile

(2S,3S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-methylpentanoic acid

C20H34N6O5S2 (502.2032)


   

Met His Cys Leu

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-methylpentanoic acid

C20H34N6O5S2 (502.2032)


   

Met His Ile Cys

(2R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-sulfanylpropanoic acid

C20H34N6O5S2 (502.2032)


   

Met His Leu Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-sulfanylpropanoic acid

C20H34N6O5S2 (502.2032)


   

Met Ile Cys His

(2S)-2-[(2R)-2-[(2S,3S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-methylpentanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H34N6O5S2 (502.2032)


   

Met Ile His Cys

(2R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C20H34N6O5S2 (502.2032)


   

Met Leu Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-methylpentanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H34N6O5S2 (502.2032)


   

Met Leu His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C20H34N6O5S2 (502.2032)


   

[(2R,3R,4R,5R)-4-acetyloxy-1-[tert-butyl(diphenyl)silyl]oxy-2,5-dihydroxy-6-oxohexan-3-yl] acetate

[(2R,3R,4R,5R)-4-acetyloxy-1-[tert-butyl(diphenyl)silyl]oxy-2,5-dihydroxy-6-oxohexan-3-yl] acetate

C26H34O8Si (502.2023)


   
   

CCG258747

CCG258747

C28H27FN4O4 (502.2016)


CCG258747 is a selective GRK2 inhibitor (IC50=18 nM) with high selectivity over GRK1, GRK5, PKA, and ROCK1 (518, 83, >5500, and >550–fold, respectively).CCG258747 also blocks the internalization of the μ-opioid receptor. G protein-coupled receptor (GPCR) kinases (GRKs) are attractive targets for the research of heart failure[1]. CCG258747 is a selective GRK2 inhibitor (IC50=18 nM) with high selectivity over GRK1, GRK5, PKA, and ROCK1 (518, 83, >5500, and >550–fold, respectively).CCG258747 also blocks the internalization of the μ-opioid receptor. G protein-coupled receptor (GPCR) kinases (GRKs) are attractive targets for the research of heart failure[1].